logo

Quick Facts

Share SHARE

Australian mining giant Rio Tinto Plc (RTNTF, RIO, RIO.L, RTPPF) Monday reported a 6 percent increase in Pilbara iron ore shipments for the third quarter. Pilbara iron ore shipments increased to 85.8 million tons from the same quarter of 2016. Pilbara iron ore production rose 2 percent to 85.0 million...

Arthur J. Gallagher & Co. (AJG) Monday announced the acquisition of Reynolds & Rodar Insurance Group, Inc. The financial aspects of the deal were not revealed. Patrick Gallagher, Jr., Chairman, President and CEO, said Reynolds & Rodar is a high-quality organization with outstanding clients that shares...

Emerson (EMR) announced it has agreed to acquire Paradigm, a provider of software solutions for the oil and gas industry, for a purchase price of $510 million. Paradigm is headquartered in Houston and has more than 500 employees globally. The company provides an array of tools that enable customers to...

Schwab Advisor Services, a unit of Charles Schwab Corp. (SCHW), said it has launched a national television advertising campaign that supports independent financial advisors. Schwab's "Independent Difference" TV spots begin airing in steady rotation today on CNBC and Fox Business Network. The ads...

Ruby Tuesday, Inc. (RT), which is struggling with lower traffic at its casual restaurants, said Monday that it has agreed to be acquired by a fund managed by NRD Capital, an Atlanta-based private equity firm that specializes in franchised and multi-location business investments. Under the terms of...

Canon U.S.A., Inc. announced PowerShot G1 X Mark III point-and shoot compact camera with a 24.3- megapixel APS-C CMOS sensor and Dual Pixel CMOS Auto-Focus technology. Dust and water resistant, the G1 X Mark III comes with a wide-angle 24-72mm (3x zoom) lens with Optical Image Stabilization featuring...

Exelixis, Inc. (EXEL) announced Monday that its global phase 3 CELESTIAL trial of Cabometyx (Cabozantinib) met its primary endpoint of overall survival in patients with advanced hepatocellular carcinoma or HCC. Separately, Exelixis announced that the FDA granted priority review for Cabozantinib as a...

Regeneron Pharmaceuticals, Inc. (REGN) and French drug giant Sanofi SA (SNYNF, SNY) announced positive results from a Phase 2 investigational study of dupilumab in adults with active moderate-to-severe eosinophilic esophagitis. The study showed that patients who received dupilumab weekly reported...

General Electric Company (GE) announced that Rafael Santana, president and CEO of GE Latin America, has been named president and CEO of GE Transportation, effective November 1, 2017. Rafael Santana will succeed Jamie Miller, who will become chief financial officer of GE on November 1, 2017. With over...

Southern Co. (SO) and its subsidiary Southern Company Gas said that Pivotal Utility Holdings, Inc., a subsidiary of Southern Company Gas, has entered into agreements to sell the assets of its utility operating divisions Elizabethtown Gas and Elkton Gas to South Jersey Industries Inc. (SJI) in an all-cash...

UTStarcom (UTSI) reported net income attributable to shareholders for the first half of 2017 of $8.3 million, compared to $3.8 million for the corresponding period in 2016. Basic income per share was $0.24, compared to $0.10. Non-GAAP basic net income per share was $0.25, compared to $0.16. First-half...

Pfizer Inc. (PFE) Monday announced that its Phase 2 study of next-generation investigational ALK-Inhibitor Lorlatinib exhibited clinically meaningful activity against lung tumors and brain metastases. The company presented the full results from the trial of the investigational, next-generation tyrosine...

Inovio Pharmaceuticals, Inc. (INO) announced Monday the initiation of a phase 1b/2 cancer efficacy trial combining its T-cell Immunotherapy with a PD-L1 Checkpoint Inhibitor in advanced bladder cancer. The immuno-oncology trial evaluates Genentech/Roche's atezolizumab (TECENTRIQ) in combination with...

Linde plc (PX) announced the proposed business combination between Praxair, Inc. (PX) and Linde AG has received unconditional antitrust clearance in Russia, satisfying a closing condition. The business combination remains subject to the satisfaction of other transaction closing conditions, including...

Eli Lilly and Company (LLY) reported new subgroup analysis from the company's Phase 3 REVEL trial of CYRAMZA (ramucirumab) in advanced non-small cell lung cancer. The global, randomized, double-blind, placebo-controlled REVEL Phase 3 study evaluated ramucirumab, in combination with docetaxel, in patients...

Follow RTT